Corium Inc.
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us

Archives

Author Archives: georgeboots

January 27, 2020

By admin admin - Press Release

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease
MENLO PARK, Calif., January 27, 2020 (GLOBE NEWSWIRE) – Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for ADLARITY (donepezil transdermal system), its lead investigational agent for the treatment of dementia of the Alzheimer’s type in patients with mild, moderate, and severe Alzheimer’s disease. FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of July 30th, 2020.

April 2, 2019

By admin admin - Press Release

Corium Appoints Perry Sternberg as Chief Executive Officer
MENLO PARK, Calif., April 2, 2019 (GLOBE NEWSWIRE) – Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas in diverse markets…

November 27, 2018

By admin admin - Press Release

Gurnet Point Capital Announces Completion of Tender Offer
CAMBRIDGE, Mass., November 27, 2018 – Gurnet Point Capital (“Gurnet Point”), a private investment firm focused on the healthcare and life sciences sectors, announced today that it has completed the previously announced tender offer for all outstanding shares of common stock of Corium International, Inc. (Nasdaq: CORI) (“Corium”), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products….

October 11, 2018

By admin admin - Press Release

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares
Total Transaction Valued in Excess of $500 Million , Representing a 50% Premium Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex Donepezil MENLO PARK, Calif. , Oct. 11, 2018 (GLOBE NEWSWIRE) — Corium International, Inc….

September 24, 2018

By admin admin - Press Release

Corium to Present at the 2018 Cantor Fitzgerald Global Heathcare Conference
MENLO PARK, Calif. , Sept. 24, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…

Page 1 of 21123›»

Archives

  • January 2020
  • April 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • August 2016
  • July 2016
  • May 2016
  • March 2016
  • February 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • May 2015
  • April 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • September 2014
  • August 2014
  • May 2014
  • April 2014
  • March 2014
  • December 2012
  • February 2011
  • May 2010
  • November 2009
  • November 2007
  • September 2007

Recent Posts

  • January 27, 2020
  • April 2, 2019
  • November 27, 2018
  • October 11, 2018
  • September 24, 2018
  • Home
  • Who We Are
  • What We Do
  • News & Media
  • Join Us
  • Contact Us
  • Terms of Use
  • Privacy Policy








© 2020 Corium Inc. All rights reserved.